NO781688L - Fremgangsmaate ved fremstilling av farmakologisk aktive midler - Google Patents
Fremgangsmaate ved fremstilling av farmakologisk aktive midlerInfo
- Publication number
- NO781688L NO781688L NO78781688A NO781688A NO781688L NO 781688 L NO781688 L NO 781688L NO 78781688 A NO78781688 A NO 78781688A NO 781688 A NO781688 A NO 781688A NO 781688 L NO781688 L NO 781688L
- Authority
- NO
- Norway
- Prior art keywords
- tinidazole
- solution
- nitroimidazole
- drug
- aqueous solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 239000013543 active substance Substances 0.000 title description 2
- 230000000144 pharmacologic effect Effects 0.000 title 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims description 30
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 claims description 28
- 229960005053 tinidazole Drugs 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 22
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 claims description 14
- 229960005219 gentisic acid Drugs 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- PUZSUVGRVHEUQO-UHFFFAOYSA-N gentisyl alcohol Chemical compound OCC1=CC(O)=CC=C1O PUZSUVGRVHEUQO-UHFFFAOYSA-N 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- -1 dihydroxybenzyl alcohol Chemical compound 0.000 claims description 4
- 229960000282 metronidazole Drugs 0.000 claims description 4
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 4
- JOVXEDBYAWFQQX-UHFFFAOYSA-N 2-(2-methyl-5-nitroimidazol-1-yl)ethyl carbamate Chemical compound CC1=NC=C([N+]([O-])=O)N1CCOC(N)=O JOVXEDBYAWFQQX-UHFFFAOYSA-N 0.000 claims description 3
- IPWKIXLWTCNBKN-UHFFFAOYSA-N Madelen Chemical compound CC1=NC=C([N+]([O-])=O)N1CC(O)CCl IPWKIXLWTCNBKN-UHFFFAOYSA-N 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 229950005881 bamnidazole Drugs 0.000 claims description 3
- 229960004918 nimorazole Drugs 0.000 claims description 3
- MDJFHRLTPRPZLY-UHFFFAOYSA-N nimorazole Chemical compound [O-][N+](=O)C1=CN=CN1CCN1CCOCC1 MDJFHRLTPRPZLY-UHFFFAOYSA-N 0.000 claims description 3
- 229960002313 ornidazole Drugs 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 229940102223 injectable solution Drugs 0.000 claims 1
- 239000007972 injectable composition Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 238000001990 intravenous administration Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- CQRYARSYNCAZFO-UHFFFAOYSA-N o-hydroxybenzyl alcohol Natural products OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N Pyrocatechuic acid Natural products OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 208000022506 anaerobic bacteria infectious disease Diseases 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 150000004958 5-nitroimidazoles Chemical class 0.000 description 1
- 208000004881 Amebiasis Diseases 0.000 description 1
- 206010001980 Amoebiasis Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000010362 Protozoan Infections Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical class OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2037977 | 1977-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781688L true NO781688L (no) | 1978-11-15 |
Family
ID=10144988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO78781688A NO781688L (no) | 1977-05-14 | 1978-05-12 | Fremgangsmaate ved fremstilling av farmakologisk aktive midler |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS542315A (it) |
| AU (1) | AU504551B1 (it) |
| BE (1) | BE867040A (it) |
| DE (1) | DE2820992A1 (it) |
| DK (1) | DK212678A (it) |
| ES (1) | ES469749A1 (it) |
| FI (1) | FI781507A (it) |
| FR (1) | FR2390162A1 (it) |
| IL (1) | IL54687A0 (it) |
| IT (1) | IT1115599B (it) |
| LU (1) | LU79655A1 (it) |
| NL (1) | NL7805158A (it) |
| NO (1) | NO781688L (it) |
| PT (1) | PT68034B (it) |
| SE (1) | SE7805471L (it) |
| ZA (1) | ZA782736B (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3070778D1 (en) * | 1979-08-11 | 1985-07-25 | Bayer Ag | Antimycotic agents with enhanced release of the active ingredients |
| FR2624736B1 (fr) * | 1987-12-16 | 1991-03-22 | Dietlin Francois | Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole |
| CN104127379A (zh) * | 2014-08-14 | 2014-11-05 | 珠海亿邦制药股份有限公司 | 一种奥硝唑注射液及其制备方法 |
| CN110538144A (zh) * | 2019-06-13 | 2019-12-06 | 南京瓦尔生物医药有限公司 | 一种奥硝唑注射液和s-奥硝唑注射液 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032645A (en) * | 1975-06-19 | 1977-06-28 | G. D. Searle & Co. | Injectable metronidazole composition |
-
1978
- 1978-05-10 IL IL54687A patent/IL54687A0/xx unknown
- 1978-05-11 ES ES469749A patent/ES469749A1/es not_active Expired
- 1978-05-12 NL NL7805158A patent/NL7805158A/xx not_active Application Discontinuation
- 1978-05-12 LU LU79655A patent/LU79655A1/xx unknown
- 1978-05-12 DE DE19782820992 patent/DE2820992A1/de active Pending
- 1978-05-12 DK DK212678A patent/DK212678A/da not_active Application Discontinuation
- 1978-05-12 NO NO78781688A patent/NO781688L/no unknown
- 1978-05-12 BE BE187664A patent/BE867040A/xx unknown
- 1978-05-12 SE SE7805471A patent/SE7805471L/xx unknown
- 1978-05-12 IT IT23351/78A patent/IT1115599B/it active
- 1978-05-12 ZA ZA00782736A patent/ZA782736B/xx unknown
- 1978-05-12 FR FR7814291A patent/FR2390162A1/fr not_active Withdrawn
- 1978-05-12 FI FI781507A patent/FI781507A/fi not_active Application Discontinuation
- 1978-05-12 AU AU36078/78A patent/AU504551B1/en not_active Expired
- 1978-05-12 PT PT68034A patent/PT68034B/pt unknown
- 1978-05-13 JP JP5706378A patent/JPS542315A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT7823351A0 (it) | 1978-05-12 |
| FR2390162A1 (fr) | 1978-12-08 |
| NL7805158A (nl) | 1978-11-16 |
| BE867040A (fr) | 1978-11-13 |
| IT1115599B (it) | 1986-02-03 |
| PT68034B (en) | 1979-10-24 |
| LU79655A1 (fr) | 1979-12-06 |
| AU504551B1 (en) | 1979-10-18 |
| JPS542315A (en) | 1979-01-09 |
| DK212678A (da) | 1978-11-15 |
| ES469749A1 (es) | 1978-12-16 |
| ZA782736B (en) | 1979-05-30 |
| DE2820992A1 (de) | 1978-12-07 |
| IL54687A0 (en) | 1978-07-31 |
| SE7805471L (sv) | 1978-11-15 |
| PT68034A (en) | 1978-06-01 |
| FI781507A (fi) | 1978-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO175406B (no) | Fremgangsmåte ved fremstilling av piroxam i vandig opplösning | |
| US9265837B1 (en) | 5α-androstane-3β,5,6β-triol injection and preparation method therefor | |
| CN105434373B (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
| IL48122A (en) | Injectable pharmaceutical compositions containing a penicillin derivative and container or syringe therefor | |
| NO171723B (no) | Fremgangsmaate for fremstilling av pentamidinsalter, nyttige i behandling av profylakse av pneumocystis carinii pneumonia | |
| NO781688L (no) | Fremgangsmaate ved fremstilling av farmakologisk aktive midler | |
| CN105213330A (zh) | 一种帕瑞昔布钠冻干制剂及其制备方法 | |
| CN109200023A (zh) | 一种注射用含盐酸丙帕他莫的药物组合物 | |
| CN111346061B (zh) | 绿原酸组合物及其制备方法 | |
| EP0003682B1 (en) | Process for solubilizing an insoluble drug and an aqueous solution prepared by this process | |
| NO333364B1 (no) | Vandig injeksjonslosning omfattende en LHRH-antagonist samt en fremgangsmate for fremstilling | |
| US4889862A (en) | Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids | |
| CN113730344B (zh) | 一种可注射用萘普生制剂及其应用 | |
| DK159376B (da) | Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid | |
| CN101491495B (zh) | 丹酚酸b镁注射剂、制备方法及应用 | |
| CN103877032A (zh) | 一种注射用维库溴铵药物组合物及其制备方法 | |
| CN106913532A (zh) | 一种注射用盐酸表柔比星及其制备方法 | |
| US4327084A (en) | Aqueous solution for intravenous administration | |
| CN101780084A (zh) | 一种以左旋亚叶酸或其盐为主要成分的注射用组合物 | |
| CN107982220A (zh) | 一种防水解的注射用赖氨匹林组合物及其制备方法 | |
| CN103585119A (zh) | 一种包含依前列醇及其药用盐的稳定化制剂及其制备方法 | |
| CN103494778B (zh) | 一种埃索美拉唑钠冻干制剂及其制备方法 | |
| KR100606621B1 (ko) | 에카베트 나트륨 수성 용액 제제 | |
| US4416874A (en) | Injectable compositions of BBM-928A | |
| JP2019085338A (ja) | ボルテゾミブを含有する凍結乾燥医薬組成物 |